Logo image of CTS.CA

Converge Technology Solutions Corp (CTS.CA) Stock Fundamental Analysis

TSX:CTS - Toronto Stock Exchange - CA21250C1068 - Common Stock - Currency: CAD

5.99  0 (0%)

Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to CTS. CTS was compared to 12 industry peers in the IT Services industry. CTS has an average financial health and profitability rating. CTS is valued quite cheap, while showing a decent growth score. This is a good combination!


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

CTS had positive earnings in the past year.
In the past year CTS had a positive cash flow from operations.
In multiple years CTS reported negative net income over the last 5 years.
Each year in the past 5 years CTS had a positive operating cash flow.
CTS.CA Yearly Net Income VS EBIT VS OCF VS FCFCTS.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M

1.2 Ratios

Looking at the Return On Assets, with a value of -8.13%, CTS is in the better half of the industry, outperforming 66.67% of the companies in the same industry.
CTS has a Return On Equity (-49.54%) which is comparable to the rest of the industry.
The Return On Invested Capital of CTS (5.10%) is better than 83.33% of its industry peers.
The Average Return On Invested Capital over the past 3 years for CTS is in line with the industry average of 5.90%.
The 3 year average ROIC (4.32%) for CTS is below the current ROIC(5.10%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA -8.13%
ROE -49.54%
ROIC 5.1%
ROA(3y)-2.33%
ROA(5y)-1.28%
ROE(3y)-15.08%
ROE(5y)-9.35%
ROIC(3y)4.32%
ROIC(5y)6.82%
CTS.CA Yearly ROA, ROE, ROICCTS.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 0 100 200 300 400

1.3 Margins

CTS's Operating Margin of 2.35% is fine compared to the rest of the industry. CTS outperforms 75.00% of its industry peers.
In the last couple of years the Operating Margin of CTS has grown nicely.
With a Gross Margin value of 26.68%, CTS perfoms like the industry average, outperforming 41.67% of the companies in the same industry.
CTS's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 2.35%
PM (TTM) N/A
GM 26.68%
OM growth 3Y-11.63%
OM growth 5Y6.89%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5.64%
GM growth 5Y2.57%
CTS.CA Yearly Profit, Operating, Gross MarginsCTS.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20

4

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), CTS is destroying value.
Compared to 1 year ago, CTS has less shares outstanding
Compared to 5 years ago, CTS has more shares outstanding
CTS has a better debt/assets ratio than last year.
CTS.CA Yearly Shares OutstandingCTS.CA Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
CTS.CA Yearly Total Debt VS Total AssetsCTS.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.2 Solvency

CTS has an Altman-Z score of 1.45. This is a bad value and indicates that CTS is not financially healthy and even has some risk of bankruptcy.
CTS has a Altman-Z score of 1.45. This is in the better half of the industry: CTS outperforms 75.00% of its industry peers.
The Debt to FCF ratio of CTS is 1.13, which is an excellent value as it means it would take CTS, only 1.13 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 1.13, CTS belongs to the top of the industry, outperforming 91.67% of the companies in the same industry.
CTS has a Debt/Equity ratio of 0.80. This is a neutral value indicating CTS is somewhat dependend on debt financing.
CTS's Debt to Equity ratio of 0.80 is in line compared to the rest of the industry. CTS outperforms 50.00% of its industry peers.
Even though the debt/equity ratio score it not favorable for CTS, it has very limited outstanding debt, so we won't put too much weight on the DE evaluation.
Industry RankSector Rank
Debt/Equity 0.8
Debt/FCF 1.13
Altman-Z 1.45
ROIC/WACC0.66
WACC7.77%
CTS.CA Yearly LT Debt VS Equity VS FCFCTS.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

2.3 Liquidity

CTS has a Current Ratio of 0.93. This is a bad value and indicates that CTS is not financially healthy enough and could expect problems in meeting its short term obligations.
CTS's Current ratio of 0.93 is on the low side compared to the rest of the industry. CTS is outperformed by 66.67% of its industry peers.
A Quick Ratio of 0.89 indicates that CTS may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.89, CTS is doing worse than 66.67% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.93
Quick Ratio 0.89
CTS.CA Yearly Current Assets VS Current LiabilitesCTS.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 22.64% over the past year.
CTS shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 86.63% yearly.
Looking at the last year, CTS shows a decrease in Revenue. The Revenue has decreased by -4.18% in the last year.
CTS shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 30.39% yearly.
EPS 1Y (TTM)22.64%
EPS 3Y86.63%
EPS 5YN/A
EPS Q2Q%21.05%
Revenue 1Y (TTM)-4.18%
Revenue growth 3Y19.27%
Revenue growth 5Y30.39%
Sales Q2Q%4.56%

3.2 Future

CTS is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 8.54% yearly.
The Revenue is expected to grow by 2.44% on average over the next years.
EPS Next Y-3.97%
EPS Next 2Y3.29%
EPS Next 3Y8.54%
EPS Next 5YN/A
Revenue Next Year2.01%
Revenue Next 2Y3.48%
Revenue Next 3Y2.44%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
CTS.CA Yearly Revenue VS EstimatesCTS.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B 2B 2.5B
CTS.CA Yearly EPS VS EstimatesCTS.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.2 0.4 0.6 0.8

7

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 9.22, the valuation of CTS can be described as very reasonable.
Based on the Price/Earnings ratio, CTS is valued cheaply inside the industry as 91.67% of the companies are valued more expensively.
CTS's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 28.78.
A Price/Forward Earnings ratio of 9.60 indicates a reasonable valuation of CTS.
Based on the Price/Forward Earnings ratio, CTS is valued cheaper than 91.67% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of CTS to the average of the S&P500 Index (21.32), we can say CTS is valued rather cheaply.
Industry RankSector Rank
PE 9.22
Fwd PE 9.6
CTS.CA Price Earnings VS Forward Price EarningsCTS.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CTS is valued cheaply inside the industry as 91.67% of the companies are valued more expensively.
83.33% of the companies in the same industry are more expensive than CTS, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 4.23
EV/EBITDA 7.98
CTS.CA Per share dataCTS.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10

4.3 Compensation for Growth

The decent profitability rating of CTS may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y3.29%
EPS Next 3Y8.54%

2

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 1.00%, CTS has a reasonable but not impressive dividend return.
CTS's Dividend Yield is rather good when compared to the industry average which is at 0.71. CTS pays more dividend than 100.00% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.46, CTS's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 1%

5.2 History

CTS is new to the dividend game and has less than 3 years of track record.
Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years1
CTS.CA Yearly Dividends per shareCTS.CA Yearly Dividends per shareYearly Dividends per share 2023 2024 0.02 0.04 0.06

5.3 Sustainability

The earnings of CTS are negative and hence is the payout ratio. CTS will probably not be able to sustain this dividend level.
DP-6.06%
EPS Next 2Y3.29%
EPS Next 3Y8.54%
CTS.CA Yearly Income VS Free CF VS DividendCTS.CA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M

Converge Technology Solutions Corp

TSX:CTS (4/23/2025, 7:00:00 PM)

5.99

0 (0%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)03-05 2025-03-05/amc
Earnings (Next)05-13 2025-05-13
Inst Owners32.73%
Inst Owner ChangeN/A
Ins Owners5.89%
Ins Owner ChangeN/A
Market Cap1.13B
Analysts73.33
Price Target5.92 (-1.17%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1%
Yearly Dividend0.05
Dividend Growth(5Y)N/A
DP-6.06%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)48.7%
Min EPS beat(2)24.14%
Max EPS beat(2)73.27%
EPS beat(4)3
Avg EPS beat(4)29.84%
Min EPS beat(4)-14.02%
Max EPS beat(4)73.27%
EPS beat(8)6
Avg EPS beat(8)23.18%
EPS beat(12)10
Avg EPS beat(12)27.25%
EPS beat(16)10
Avg EPS beat(16)8.62%
Revenue beat(2)1
Avg Revenue beat(2)1.69%
Min Revenue beat(2)-1.98%
Max Revenue beat(2)5.36%
Revenue beat(4)2
Avg Revenue beat(4)-0.94%
Min Revenue beat(4)-7.62%
Max Revenue beat(4)5.36%
Revenue beat(8)5
Avg Revenue beat(8)1.15%
Revenue beat(12)7
Avg Revenue beat(12)-2.47%
Revenue beat(16)9
Avg Revenue beat(16)-1.7%
PT rev (1m)6.33%
PT rev (3m)15.06%
EPS NQ rev (1m)-10.96%
EPS NQ rev (3m)-11.37%
EPS NY rev (1m)-0.32%
EPS NY rev (3m)2.43%
Revenue NQ rev (1m)-0.08%
Revenue NQ rev (3m)-0.32%
Revenue NY rev (1m)0.92%
Revenue NY rev (3m)1.11%
Valuation
Industry RankSector Rank
PE 9.22
Fwd PE 9.6
P/S 0.44
P/FCF 4.23
P/OCF 4.21
P/B 3.15
P/tB N/A
EV/EBITDA 7.98
EPS(TTM)0.65
EY10.85%
EPS(NY)0.62
Fwd EY10.42%
FCF(TTM)1.41
FCFY23.62%
OCF(TTM)1.42
OCFY23.75%
SpS13.74
BVpS1.9
TBVpS-1.65
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -8.13%
ROE -49.54%
ROCE 7.08%
ROIC 5.1%
ROICexc 6.11%
ROICexgc 90.81%
OM 2.35%
PM (TTM) N/A
GM 26.68%
FCFM 10.3%
ROA(3y)-2.33%
ROA(5y)-1.28%
ROE(3y)-15.08%
ROE(5y)-9.35%
ROIC(3y)4.32%
ROIC(5y)6.82%
ROICexc(3y)5.23%
ROICexc(5y)10.33%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)6%
ROCE(5y)9.47%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3Y-4.82%
ROICexc growth 5Y-27.87%
OM growth 3Y-11.63%
OM growth 5Y6.89%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5.64%
GM growth 5Y2.57%
F-Score5
Asset Turnover1.19
Health
Industry RankSector Rank
Debt/Equity 0.8
Debt/FCF 1.13
Debt/EBITDA 1.77
Cap/Depr 1.44%
Cap/Sales 0.06%
Interest Coverage 2.57
Cash Conversion 166.18%
Profit Quality N/A
Current Ratio 0.93
Quick Ratio 0.89
Altman-Z 1.45
F-Score5
WACC7.77%
ROIC/WACC0.66
Cap/Depr(3y)13.45%
Cap/Depr(5y)14.95%
Cap/Sales(3y)0.52%
Cap/Sales(5y)0.5%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)22.64%
EPS 3Y86.63%
EPS 5YN/A
EPS Q2Q%21.05%
EPS Next Y-3.97%
EPS Next 2Y3.29%
EPS Next 3Y8.54%
EPS Next 5YN/A
Revenue 1Y (TTM)-4.18%
Revenue growth 3Y19.27%
Revenue growth 5Y30.39%
Sales Q2Q%4.56%
Revenue Next Year2.01%
Revenue Next 2Y3.48%
Revenue Next 3Y2.44%
Revenue Next 5YN/A
EBIT growth 1Y30.87%
EBIT growth 3Y5.4%
EBIT growth 5Y39.37%
EBIT Next Year259.93%
EBIT Next 3Y59.08%
EBIT Next 5YN/A
FCF growth 1Y22.02%
FCF growth 3Y48.95%
FCF growth 5Y60.56%
OCF growth 1Y16.89%
OCF growth 3Y45.52%
OCF growth 5Y58.51%